Posts by David Griscom
Since 2007 the IRS Whistleblower Program has helped recover $3.7 billion back to the U.S. Treasury, but there is still plenty of room for improvement.
According to a new study by Jaron H. Wilde and other researchers at the University of Iowa, whistleblower-initiated investigations in the financial sector:
A new study by Dr. Genevieve Pham-Kanter of Drexel University claims that 65% of patients in the US, "visited a doctor within the last year who had received payments or gifts from pharmaceutical or medical device companies."
US Attorney Preet Bharara said that 'slush funds' held by the government, should set off the alarm bells for all honest elected officials:
“The public deserves to see where their money is going and for what purpose. Who puts the money in? Are there subcontractors? Shell companies? Be on top of that. Be wary of slush funds for council members.”
The Los Angeles Times recently explored the high cost of fast tracking drugs at the Food and Drug Administration.
In an interview with Roll Call, Grassley made his position on whistleblowers transparent:
Senator Grassley explained in an interview with Roll Call about some of his thoughts on the new adminstration and a letter that he penned with Represenative Chaffetz and Represenative Mark Meadows:
MedStar Ambulance Inc. will pay $12.7 million to settle a non-intervened upcoding case in Massachusetts. This case was initially declined by the government, but because of the tenacity and hard work of attorney Jeffrey Newman, and the courage of relator Dale Meehan, it moved forward and, in the end, they were awarded a 28% relator share for their extraordinary efforts.
- 1 of 6
- next ›